Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 4—April 2005
Perspective

Emerging Infectious Diseases: a 10-Year Perspective from the National Institute of Allergy and Infectious Diseases

Anthony S. Fauci*, Nancy A. Touchette*Comments to Author , and Gregory K. Folkers*
Author affiliations: *National Institutes of Health, Bethesda, Maryland, USA

Main Article

Figure 3

Budget of the National Institute for Allergy and Infectious Disease (NIAID), FY1994–2005. The overall NIAID budget rose from $1.06 billion in FY1994 to $4.4 billion (estimated) in FY2005. Funding for emerging infectious diseases rose from $47.2 million in FY1994 to $1.74 billion in FY2005 (est.).

Figure 3. Budget of the National Institute for Allergy and Infectious Disease (NIAID), FY1994–2005. The overall NIAID budget rose from $1.06 billion in FY1994 to $4.4 billion (estimated) in FY2005. Funding for emerging infectious diseases rose from $47.2 million in FY1994 to $1.74 billion in FY2005 (est.).

Main Article

Page created: May 23, 2011
Page updated: May 23, 2011
Page reviewed: May 23, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external